Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (2), 243-248
- https://doi.org/10.1016/0959-8049(95)00444-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive daysEuropean Journal Of Cancer, 1994
- Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Modulation of deoxycytidylate deaminase in intact human leukemia cells: Action of 2',2'-difluorodeoxycytidineBiochemical Pharmacology, 1992
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancerInvestigational New Drugs, 1990
- 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia CellsNucleosides, Nucleotides and Nucleic Acids, 1989
- A phase II study of etoposide and splitted doses of CDDP for the treatment of non small cell lung cancerLung Cancer, 1986
- A review of etoposide in patients with non-small-cell lung cancer (NSCLC)Cancer Treatment Reviews, 1982